telch

Dr. MICHAEL J. TELCH


 





Ph.D., Stanford University (Dissertation Chair: Dr. W. Stewart Agras). Texas License No. 3316 Psychologist.  Professor of Psychology University of Texas at Austin. 1993-1999, Director of Clinical Training, Department of Psychology, The University of Texas at Austin. 2010, Fifth Honorary Revesz Professor, Department of Psychology, University of Amsterdam. 2009-Present, Fellow, Association for Psychological Science.  2005 Dean’s Fellowship, University of Texas. 2003-Present, Fellow, American Association of Applied and reventive Psychology.

Member, NIMH Treatment and Assessment (TA) Study Section
Member, Scientific Advisory Board of the NIMH National Panic Disorder Education Program
Panel Member, NIMH Panic Disorder Assessment Committee
Panel Member, Panic Disorder Consensus Conference
Editorial Board, Journal of Anxiety Disorders (1987-1993)
Editorial Board, Phobia Research and Practice (1988-1991)
Editorial Board, Journal of Behavior Therapy and Experimental Psychiatry (2006 to present)
Ad hoc reviewer Journal of Abnormal Psychology
Ad hoc reviewer Journal of Consulting and Clinical Psychology
Ad hoc reviewer Clinical Psychology Review
Ad hoc reviewer Psychological Bulletin
Ad hoc reviewer Journal of Nervous and Mental Disease
Ad hoc reviewer Journal of the American Medical Association
Ad hoc reviewer Cognitive Therapy and Research
Ad hoc reviewer American Journal of Public Health
Ad hoc reviewer Behavior Therapy
Ad hoc reviewer Behaviour Research and Therapy
Ad hoc reviewer Journal of Behavioral Medicine
Ad hoc reviewer Addictive Behaviors
Ad hoc reviewer Anxiety Research


RESUMEN/ABSTRACT/RESUMO



SESIÓN APLICADA/KEYNOTE/SESSÃO APLICADA

Recent developments in exposure treatments for anxiety disorders

 
        

Exposure to fear-provoking cues is a central procedural element in almost all empirically supported treatments for anxiety disorders. In his talk, the speaker will address four key questions: (1) What are the major types of exposure techniques used with anxiety disordered patients? (2) What clinical strategies enhance the efficacy of exposure treatments? (3) What are the change mechanisms governing exposure therapy; and (4) How can clinicians on the front lines increase their effectiveness with anxiety patients? In addressing these questions the speaker will first review a series of experiments investigating several exposure augmentation strategies and their effects on treatment outcome. The strategies reviewed will include: (a) attentional strategies; (b) feedback strategies; (c) use of safety behaviors; (d) use of antagonistic actions, and (e) pharmacological strategies.The final segment of the talk will provide a set of recommendations for clinicians in their work with anxiety patients.